The COVID-19 vaccine was a triumph of science. Governments, researchers, and vaccine manufacturers worked in tandem to ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturing ...

WHO-origin Master and Working Cell Banks provide vaccine developers with a ready-to-use Vero cell substrate for licensing, purchase, and integrated CDMO programs ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

Emerging and neglected tropical diseases continue to pose major public health challenges across low- and middle-income ...

Read Covid-19 Vaccine latest news on The Economic Times. When will Covid-19 Vaccine be available in India? Covid-19 Vaccine ...

mRNA technology is enabling an entirely new HIV vaccine strategy that, for the first time, successfully primes the immune system toward broadly neutralizing antibodies in humans. The TB vaccine ...